20525 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
Hepatitis C virus inhibitors
#602NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
#603Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#604Dermal Delivery
#605ADVANCED METHOD OF TREATMENT AND MANAGEMENT OF CHRONIC HEPATITIS C INFECTION
#606Compositions Associated with and Methods of Managing Neutrophil Movement
#607Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#608Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use
#609Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
#610MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#611Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient
#612Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
#613Combinations comprising biphenyl derivatives for use in the treatment of HCV
#614ISOLATION OF NOVEL BIOACTIVE COMPOUND OBTAINED FROM OIL PALM BASE MATERIALS
#615Chemical compounds
#616THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
#617Compounds and methods for treating bacterial infections
#618METHODS OF USING CLEAVABLE DRUG CONJUGATES AND COMPOSITIONS THEREOF
#619MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE
#620Sphingoglycolipid analogues
#621Cyclosporin analogues for preventing or treating hepatitis C infection
#622Multi-functional composition and preparation method and application thereof
#623Pyrazole derivative and use thereof for medical purposes
#624Cleavable drug conjugates, compositions thereof and methods of use
#625Methods for the preparation of ribosides
#626ANTI-ACNE COMPOSITION AND METHODS OF USE THEREOF
#627Antiviral compounds
#6283-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
#629Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
#630Compositions and methods for treating coronavirus infection
#631METHOD TO ENHANCE DELIVERY OF GLUTATHIONE AND ATP LEVELS IN CELLS
#632Biodefenses using triazole-containing macrolides
#633Inhibitors and methods of inhibiting bacterial and viral pathogens
#634Topical Composition and Carrier for Administration of Pharmaceutically or Cosmetically Active Ingredients
#635Anti-wall teichoic antibodies and conjugates
#636Methods, uses and compositions of Tie2 agonists
#637COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS
#6382′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#639Antibacterial compounds targeting isoprenoid biosynthesis
#640Compositions and methods for treating viral infections
#641RIFAXIMIN FOR USE IN THE TREATING OF VAGINAL INFECTIONS
#642Use of PACAP for the treatment of viral infections in aquatic organisms
#643NOVEL CRYSTALLINE FORMS OF AN ANTIVIRAL BENZIMIDAZOLE COMPOUND
#644Methods and materials for reducing the risk of infections
#645Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
#646STABILIZED NUCLEOTIDES FOR MEDICAL TREATMENT
#647SYSTEM, RETAINER AND METHOD OF PROVIDING THERAPEUTIC TREATMENT FOR ACNE
#648Modulators of toll-like receptors
#649Dental and medical devices with light source and antimicrobial solution
#650Anti-wall teichoic antibodies and conjugates
#651Vitamin preparation
#652CLINDAMYCIN PHOSPHATE, SALICYLIC ACID AND TEA TREE OIL COMBINATIONS
#653Use of levocetirizine and montelukast in the treatment of traumatic injury
#654Solid forms of an antiviral compound
#655Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases
#656Thiourea derivatives
#657Non-medical increase or maintenance of body weight of a mammal
#658Hyaluronate compositions
#659N-METHYLSEROTONIN AND RELATED SUBSTANCES FOR USE IN TREATING / LESSENING THE OCCURRENCE OF HOT FLASHES RELATED TO MENOPAUSE
#660Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor
#661Therapeutic methods
#662Retinoid topical compositions and methods for treating skin conditions
#663Hepatitis C virus inhibitors
#664Small molecule substance for improving sensitivity of bacteria to antibiotics
#665TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS
#666Methods for Treating HCV
#667Macrocyclic inhibitors of flaviviridae viruses
#668Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
#6692′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#670TREATMENTS OF HEPATITIS C VIRUS INFECTION
#671Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
#672Treatment of metabolic disorders in equine animals
#673Microbial-relief composition
#674Betalain compositions and methods therefor
#675Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
#676Nucleotide prodrug compounds and use
#677Hepatitis C virus inhibitors
#678Treatment and prevention of infections using coformycin analogs
#679METHODS OF TREATING AN INFLAMMATORY-RELATED DISEASE
#680Nano-targeted delivery of protease, polymerase inhibitors with or without immune modulators in the treatment of hepatitis C
#681Bifunctional cytotoxic agents
#682Antibacterial composition for topical use
#683Effective treatment of ovarian cancer using triciribine and related compounds
#684COMBINATION THERAPY FOR ACNE VULGARIS COMPRISING ADMINISTRATION OF ADAPALENE 0.3% GEL AND CLINDAMYCIN/BENZOYL PEROXIDE GEL
#685Compounds and methods for treating bacterial infections
#686COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS
#687Process for preparing antiviral compounds
#688COMBINATION PREPARATIONS OF 3-N-FORMYL HYDROXY AMINO PROPYL PHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYL HYDROXY AMINO PROPYL PHOSPHONIC ACID DERIVATIVES TOGETHER WITH SPECIAL PHARMACEUTICAL ACTIVE INGREDIENTS
#689Azido nucleosides and nucleotide analogs
#690Solid forms of a thiophosphoramidate nucleotide prodrug
#691Translocation of non-natural chemical entities through anthrax protective antigen pore
#692Methods for Treating HCV
#693COMBINATION THERAPY FOR TREATING HCV INFECTION IN AN HCV-HIV COINFECTED PATIENT POPULATION
#694TRANSGENIC PLANTS EXPRESSING COBALAMIN BINDING PROTEINS
#695Protein retrosplicing enabled by a double ligation reaction
#696METHODS OF TREATING HEPATITIS C VIRUS INFECTION IN SUBJECTS WITH CIRRHOSIS
#697Compositions and methods for treating hepatitis C virus
#698Tetracyclic compound
#699COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUBGENOTYPE SUB-POPULATION
#700Solid forms of an antiviral compound
#701Pyrazole derivative and use thereof for medical purposes
#702Substituted nucleotide analogs
#703Methods for treating HCV
#704Antiviral compounds
#705ALISPORIVIR TO TREAT HEPATITIS C VIRUS INFECTION
#706MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#707Hepatitis C virus inhibitors
#708Methods for treating resistant diseases using triazole containing macrolides
#709Treatments of Hepatitis C virus infection
#710Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#711FORMULATIONS OF ACADESINE
#712Methods of Treating Hepatitis C Virus Infection
#713Anthracycline-antibody conjugates for cancer therapy
#714Compositions and methods for amelioration and prevention of drug-induced toxicity
#715Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#716Spiro[2.4]heptanes for treatment of Flaviviridae infections
#717COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
#718Agent for the treatment of viral hepatitis C
#719Leptin Compositions and Methods for Treating Progressive Cognitive Function Disorders Resulting from Accumulation of Neurofibrillary Tangles and Amyloid Beta
#720Methods for Treating HCV
#721Methods for treating HCV
#722HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#723Hepatitis C Virus Inhibitors
#724Synthetic mechanical hemostatic composition, method of making and use thereof
#725MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#726Methods for Treating HCV
#727METHODS FOR TREATING OCULAR INFLAMMATORY DISORDERS
#728Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
#729Poloxamer Based Inhalation Composition
#730COMBINATION THERAPY FOR ACNE VULGARIS COMPRISING ADMINISTRATION OF ADAPALENE 0.3% GEL AND CLINDAMYCIN/BENZOYL PEROXIDE GEL
#731COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS
#732Conjugate-based antifungal and antibacterial prodrugs
#733COMPOSITIONS FOR THE TREATMENT OF MUCOUS MEMBRANE DISEASES
#734Anti-human respiratory syncytial virus (RSV) antibodies and methods of use
#735ONCE DAILY TREATMENT OF HEPATITIS C WITH RIBAVIRIN AND TARIBAVIRIN
#736METHODS OF PREVENTING AND TREATING RECURRENCE OF A HEPATITIS C VIRUS INFECTION IN A SUBJECT AFTER THE SUBJECT HAS RECEIVED A LIVER TRANSPLANT
#737Methods and compositions for treating lupus
#738Advanced methods and systems for treating cell proliferation disorders
#739Combination therapy using ribavirin as eIF4E inhibitor
#740Benzimidazole derivatives
#741COMBINATION THERAPY FOR TREATING HCV INFECTION IN AN HCV-HIV COINFECTED PATIENT POPULATION
#742Anionic conjugates of glycosylated bacterial metabolite
#743INHIBITORS OF HEPATITIS C VIRUS POLYMERASE
#744Modulators of toll-like receptors
#745Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient
#746Antiviral compounds
#747Solid forms of an antiviral compound
#748Hepatitis C virus inhibitors
#749BIOMARKERS FOR HCV INFECTED PATIENTS
#750Hepatitis C viral infection treatment using a combination of compounds
#751Drug formulations
#752Antisense antiviral compound and method for treating influenza viral infection
#753HCV NS3 protease inhibitors
#754Oligomer conjugates of heteropentacyclic nucleosides
#755Inhibitors of hepatitis C virus
#756Veterinary active agent application
#757METHODS FOR DETERMINING VIRAL SENSITIVITY TO VIRAL INHIBITORS
#758METHODS FOR TREATING HCV
#759COMPOSITIONS CONTAINING NITRO FATTY ACIDS
#760Anti-biofilm compositions and methods for using
#761COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUBGENOTYPE SUB-POPULATION
#762Compounds and pharmaceutical compositions for the treatment of viral infections
#763METHODS FOR TREATING HEPATITIS C VIRUS INFECTION
#7643′-deoxy nucleosides for the treatment of HCV
#765Foamable suspension gel
#766Anti-HCV agent
#767COMBINATION THERAPY FOR TREATING HCV INFECTION IN AN HCV-HIV COINFECTED PATIENT POPULATION
#7685′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#769Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#770INHIBITING GS-FDH TO MODULATE NO BIOACTIVITY
#771Combination Treatments For Hepatitis C
#772HCV helicase inhibitors and methods of use thereof
#7735′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
#7745, 6-Duridine nucleoside/tide derivatives
#775HCV Combination Therapy
#776MARKETING N-METHYLSEROTONIN AND RELATED SUBSTANCES FOR USE IN TREATING/ LESSENING THE OCCURRENCE OF HOT FLASHES RELATED TO MENOPAUSE
#777COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
#778Therapeutic methods
#7792′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#780Hepatitis C Virus Inhibitors
#781Artonin I to treat resistant infectious
#782NOVEL AMPK AGONIST COMPOSITIONS AND METHODS OF USE
#783Topical bioadhesive formulations
#784Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same
#7854′-fluoro nucleosides for the treatment of HCV
#786Antiviral compounds
#787COMPOSITIONS FOR AMELIORATING SYSTEMIC INFLAMMATION AND METHODS FOR MAKING AND USING THEM
#788METHODS FOR THE DIAGNOSIS, TREATMENT AND MONITORING OF CANCER
#7892′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
#790Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-β
#791Solid forms of a thiophosphoramidate nucleotide prodrug
#792[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
#793METHOD AND DEVICE FOR IDENTIFICATION OF ONE CARBON PATHWAY GENE VARIANTS AS STROKE RISK MARKERS, COMBINED DATA MINING, LOGISTIC REGRESSION, AND PATHWAY ANALYSIS
#794Spiro[2.4]heptanes for treatment of flaviviridae infections
#795Spiro[2.4]heptanes for treatment of flaviviridae infections
#796Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
#797D-Alanine Ester of Sp-Nucleoside Analog
#798D-Alanine Ester of Rp-Nucleoside Analog
#799TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS
#800Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#801TREATMENT OF HEPATITIS C VIRUS WITH TELAPREVIR (VX-950) IN PATIENTS NON-RESPONSIVE TO TREATMENT WITH PEGYLATED INTERFERON-ALPHA 2A/2B AND RIBAVIRIN
#802HCV Combination Therapy
#803COMBINATION THERAPY FOR HEPATITIS C VIRUS INFECTION
#804ANTIVIRAL ACTIVITY OF TYROSINE KINASE INHIBITORS AGAINST HEPATITUS C VIRUS
#805Hepatitis C virus inhibitors
#806HCV Combination Therapy
#807Antiviral compounds
#808Methods for treating HCV
#809STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT
#810Multivalent [beta]-1-2-linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
#811METHOD OF DIAGNOSING AND TREATING EPSTEIN BARR VIRUS-BASED MYALGIC ENCEPHALOMYELITIS CHRONIC FATIGUE SYNDROME PATIENTS
#812TREATING SCHIZOPHRENIA
#813Selective glycosidase inhibitors and uses thereof
#814Use of PACAP for the treatment of viral infections in aquatic organisms
#815Method and System for Treatment of Biological Tissue
#816Esters and malonates of SATE prodrugs
#817Tetrazolones as inhibitors of fatty acid synthase
#818COMBINATION THERAPY WITH NANOPARTICLE COMPOSITIONS OF TAXANE AND HEDGEHOG INHIBITORS
#819Method for treating neurotrauma
#820Controlled release pharmaceutical formulations of nitazoxanide
#821COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS
#8222'-Branched Nucleosides for Treatment of Viral Infections
#823Hyaluronate compositions
#824Treating hepatitis C virus infection
#825TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT
#826Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#827Methods and compositions for treating thyroid-related medical conditions with reduced folates
#828Methods for Treating HCV
#829Methods for treating HCV
#830Hepatitis C virus inhibitors
#831Polycyclic agents for the treatment of respiratory syncytial virus infections
#832COMBINATION THERAPEUTIC COMPOSITION
#833Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
#834Macrocyclic inhibitors of flaviviridae viruses
#835Self solidifying bioerodible barrier implant
#836Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection
#837Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
#838Combination of Components for the Prevention and Treatment of Frailty
#839Non-medical increase or maintenance of body weight of a mammal
#840Solid forms of an antiviral compound
#841IDRABIOTAPARINUX FOR THE TREATMENT OF PULMONARY EMBOLISM AND FOR THE SECONDARY PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS
#842METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRIDAE INFECTIONS
#843METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS
#844Methods and compositions for treating flaviviruses and pestiviruses
#845Treatment and prevention of bacterial vaginosis and infections
#846ANTIVIRAL COMPOUNDS
#847Antiviral compounds
#848ORAL COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUBGENOTYPE POPULATIONS
#849Pharmaceutical compositions of anti-acne agents
#850POLYCYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
#851METHODS FOR TREATING HCV
#852Therapies for Treating Hepatitis C Virus Infection
#853Synthetic mechanical hemostatic composition, method of making and use thereof
#854Polymeric topical compositions
#855Method for treatment of acne using pharmaceutical compositions of clindamycin
#856Solid forms of a thiophosphoramidate nucleotide prodrug
#857Modulator of activity of adenylate cyclase
#858Oligomer conjugates of heteropentacyclic nucleosides
#859ORAL COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUB-POPULATION
#860BID DOSAGE REGIMEN FOR DEB025
#861Methods for treating HCV
#862NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF
#863Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#864Silibinin component for the treatment of hepatitis
#865Estrogen receptor modulators and uses thereof
#866ANTI-BACTERIAL ACTIVITY OF 9-HYDROXY DERIVATIVES OF 6,11-BICYCLOLIDES
#867NEW DRUG COMBINATIONS FOR THE TREATMENT OF MALARIA
#868Process for preparing antiviral compounds
#869IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NUEROLOGIC DISORDERS
#870Combinatory Cancer Treatment
#871Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
#872Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes
#873Glycoside derivatives and uses thereof
#874Inhibitors of HCV NS5A
#875Supporting activities of daily living
#876Compositions And Methods For Treating Or Preventing Immuno-Inflammatory Disease
#877Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent
#878Parenteral formulations of elacytarabine derivatives
#879COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONS
#880HIGH POTENCY FORMULATIONS OF VX-950
#881ORAL VETERINARIAN COMPOSITION FOR SALMONIDS COMPRISING 1-BETA-D-RIBOFURANOSYL-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE AND USE THEREOF IN THE TREATMENT OF INFECTIOUS ANEMIA IN SALMONIDS
#882Curcumin derivatives
#883Nutrient compositions and methods for enhanced effectiveness of the immune system
#884Hepatitis C virus inhibitors
#885COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
#886Methods of treating an inflammatory-related disease
#887Anti-human respiratory syncytial virus (RSV) antibodies and methods of use
#888Antiviral compounds
#889Use of 1-beta-D-ribofuranosyl-1-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anemia
#890COMPOSITION FOR TOPICAL TREATMENT OF MIXED VAGINAL INFECTIONS
#891METHODS FOR TREATING HCV
#892METHODS FOR TREATING VIRAL CONDITIONS
#8933-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
#894Substituted nucleotide analogs
#895Glycoside compounds
#896Methods and compositions for treating hepatitis C virus
#897COMBINATION OF ANTI-ENVELOPE ANTIBODIES AND ANTI-RECEPTOR ANTIBODIES FOR THE TREATMENT AND PREVENTION OF HCV INFECTION
#898Nitrogenated derivatives of pancratistatin
#899Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent
#900Pharmacogenomic and Response-Guided Treatment of Infectious Disease Using Yeast-Based Immunotherapy